Drug Profile
EMI 200
Alternative Names: EMI-200Latest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator Edinburgh Molecular Imaging
- Class Diagnostic agents; Imaging agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Lung disorders; Pneumonia
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for phase-I development in Pneumonia in Unknown (Intrapulmonary)
- 28 Oct 2018 No recent reports of development identified for phase-I development in Lung-disorders(In volunteers) in United Kingdom (Intrapulmonary)
- 24 Feb 2017 Preclinical data released by Edinburgh Molecular Imaging (Edinburgh Molecular Imaging website, February 2017)